Unknown

Dataset Information

0

Affinity-based probes based on type II kinase inhibitors.

ABSTRACT: Protein kinases are key components of most mammalian signal transduction networks and are therapeutically relevant drug targets. Efforts to study protein kinase function would benefit from new technologies that are able to profile kinases in complex proteomes. Here, we describe active site-directed probes for profiling kinases in whole cell extracts and live cells. These probes contain general ligands that stabilize a specific inactive conformation of the ATP-binding sites of protein kinases, as well as trifluoromethylphenyl diazirine and alkyne moieties that allow covalent modification and enrichment of kinases, respectively. A diverse group of serine/threonine and tyrosine kinases were identified as specific targets of these probes in whole cell extracts. In addition, a number of kinase targets were selectively labeled in live cells. Our chemical proteomics approach should be valuable for interrogating protein kinase active sites in physiologically relevant environments.

SUBMITTER: Ranjitkar P 

PROVIDER: S-EPMC3523701 | biostudies-literature | 2012 Nov

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Affinity-based probes based on type II kinase inhibitors.

Ranjitkar Pratistha P   Perera B Gayani K BG   Swaney Danielle L DL   Hari Sanjay B SB   Larson Eric T ET   Krishnamurty Ratika R   Merritt Ethan A EA   Villén Judit J   Maly Dustin J DJ  

Journal of the American Chemical Society 20121106 46

Protein kinases are key components of most mammalian signal transduction networks and are therapeutically relevant drug targets. Efforts to study protein kinase function would benefit from new technologies that are able to profile kinases in complex proteomes. Here, we describe active site-directed probes for profiling kinases in whole cell extracts and live cells. These probes contain general ligands that stabilize a specific inactive conformation of the ATP-binding sites of protein kinases, as  ...[more]

Similar Datasets

Unknown Adenosine analogue-oligo-arginine conjugates (ARCs) serve as high-affinity inhibitors and fluorescence probes of type I cGMP-dependent protein kinase (PKGIalpha).
| S-EPMC3071016 | biostudies-literature
Unknown Structure-based development of potent and selective type-II kinase inhibitors of RIPK1.
| S-EPMC10793102 | biostudies-literature
Unknown Template-based de novo design for type II kinase inhibitors and its extented application to acetylcholinesterase inhibitors.
| S-EPMC6270190 | biostudies-literature
Unknown Structure-Based Design of Type II Inhibitors Applied to Maternal Embryonic Leucine Zipper Kinase.
| S-EPMC4291807 | biostudies-other
Unknown Fluorescent kinase inhibitors as probes in cancer.
| S-EPMC8410685 | biostudies-literature
Unknown DFGmodel: predicting protein kinase structures in inactive states for structure-based discovery of type-II inhibitors.
| S-EPMC4301084 | biostudies-literature
Unknown Identification of highly selective type II kinase inhibitors with chiral peptidomimetic tails.
| S-EPMC9067983 | biostudies-literature
Unknown Discovery of type II inhibitors of TGF?-activated kinase 1 (TAK1) and mitogen-activated protein kinase kinase kinase kinase 2 (MAP4K2).
| S-EPMC4292808 | biostudies-literature
Unknown NTRK kinase domain mutations in cancer variably impact sensitivity to type I and type II inhibitors.
| S-EPMC7745027 | biostudies-literature
Unknown Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors.
| S-EPMC4579271 | biostudies-literature